STD Diagnostic Industry Outlook and Healthcare Advancements

According to Decision Advisors, the Global STD Diagnostic Market Size is expected to grow from USD 18.25 billion in 2025 to USD 35.40 billion by 2035, at a CAGR of 6.85% during the forecast period 2025–2035. The market is projected to expand steadily over the next decade, driven by the increasing global incidence of infections like Chlamydia and Syphilis and a rising emphasis on early clinical intervention. This growth is further supported by the shift toward decentralised testing, including point-of-care (POC) and home-based kits that offer users greater privacy and convenience. As government-led screening programs expand and technological advancements in molecular diagnostics make testing more accessible, the consumption of diagnostic reagents and consumables is increasing worldwide, solidifying the market’s long-term trajectory.